TY - JOUR
T1 - Association between perioperative low-molecular-weight heparin vs unfractionated heparin and clinical outcomes in patients with cancer undergoing surgery
AU - Akl, Elie A.
AU - Kahale, Lara A.
AU - Schünemann, Holger J.
AU - McDermott, Mary Mc Grae
N1 - Copyright:
Copyright 2018 Elsevier B.V., All rights reserved.
PY - 2015/4/7
Y1 - 2015/4/7
N2 - Clinical Question: In patients with cancer undergoing surgery, what is the association between perioperative thromboprophylaxis with low-molecular-weight heparin (LMWH) or unfractionated heparin and mortality, pulmonary embolism, deep venous thrombosis, thrombocytopenia, and bleeding outcomes? Bottom Line: When used for perioperative thromboprophylaxis, there are no differences in the association of LMWH vs unfractionated heparin for preventing mortality, pulmonary embolism, deep venous thrombosis, bleeding outcomes, or thrombocytopenia in patients with cancer.
AB - Clinical Question: In patients with cancer undergoing surgery, what is the association between perioperative thromboprophylaxis with low-molecular-weight heparin (LMWH) or unfractionated heparin and mortality, pulmonary embolism, deep venous thrombosis, thrombocytopenia, and bleeding outcomes? Bottom Line: When used for perioperative thromboprophylaxis, there are no differences in the association of LMWH vs unfractionated heparin for preventing mortality, pulmonary embolism, deep venous thrombosis, bleeding outcomes, or thrombocytopenia in patients with cancer.
UR - http://www.scopus.com/inward/record.url?scp=84927549656&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84927549656&partnerID=8YFLogxK
U2 - 10.1001/jama.2015.498
DO - 10.1001/jama.2015.498
M3 - Article
C2 - 25849181
AN - SCOPUS:84927549656
SN - 0098-7484
VL - 313
SP - 1364
EP - 1365
JO - JAMA - Journal of the American Medical Association
JF - JAMA - Journal of the American Medical Association
IS - 13
ER -
